Cumberland Pharmaceuticals Inks New Bank Financing Deal With Bank of America
Aug 4, 2011
|
|
|
 |
|
NASHVILLE, Tenn., Aug. 4, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced that it has executed a new senior credit agreement with Bank of America. Pursuant to the new agreement, the Company has increased its revolving line of credit to $10 million, which is expandable to $20 million. In addition, the maturity d...
|
|
Cumberland Pharmaceuticals to Announce Second Quarter 2011 Financial Results on August 4, 2011
Jul 14, 2011
|
|
|
|
|
NASHVILLE, Tenn., July 14, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that it will release second quarter 2011 financial results after the market closes on Thursday, August 4, 2011. A conference call and live Internet webcast will be held on Thursday, August 4, 2011, at 5:00 p.m. Eastern Time to discuss the...
|
|
Cumberland Pharmaceuticals to Present at the 2011 Wells Fargo Securities Healthcare Conference in Boston
Jun 7, 2011
|
|
|
|
|
NASHVILLE, Tenn., June 7, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that it will present a corporate overview at the Wells Fargo Securities Healthcare Conference in Boston at 2:30 p.m. Eastern Time on Wednesday,...
|
|
Caldolor® Clinical Study in Hospitalized Burn Patients Published in Journal of Burn Care & Research
May 16, 2011
|
|
|
|
|
NASHVILLE, Tenn., May 16, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) today announced that results from a clinical study evaluating the safety and efficacy of Caldolor® (ibuprofen) Injection in treating fever and pain in hospitalized burn patients was published in Volume 32, Number 1 of the Journal of Burn Care & Resear...
|
|
Cumberland Pharmaceuticals to Present at the 2011 UBS Global Specialty Pharmaceuticals Conference in London
May 11, 2011
|
|
|
|
|
NASHVILLE, Tenn., May 11, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that it will present a corporate overview at the 2011 UBS Global Specialty Pharmaceuticals Conference in London on Wednesday, May 25, 2011, at ...
|
|
Cumberland Pharmaceuticals Reports First Quarter 2011 Financial Results
May 4, 2011
|
|
|
|
|
NASHVILLE, Tenn., May 4, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced first quarter 2011 financial results.
Net Revenue: For the three months ended March 31, 2011, net revenue was $10.7 million, up from $10.1 m...
|
|
Cumberland Pharmaceuticals to Announce First Quarter 2011 Financial Results on May 4, 2011
Apr 22, 2011
|
|
|
|
|
NASHVILLE, Tenn., April 22, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that it will release first quarter 2011 financial results after the market closes on Wednesday, May 4, 2011. A conference call and live Internet webcast will be held on Wednesday, May 4, 2011 at 5:00 p.m. Eastern Time to discuss the resul...
|
|
Cumberland Pharmaceuticals Announces New Product Addition With Hepatoren™ (ifetroban) Injection
Apr 19, 2011
|
|
|
|
|
NASHVILLE, Tenn., April 19, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that it has entered into an agreement to acquire the rights to ifetroban, a new Phase II development product. The Company has initiated clini...
|
|
|
|
